Skip to main content
. 2017 Jan 12;28(6):1851–1858. doi: 10.1681/ASN.2016101053

Table 3.

Treatment-emergent AEs (reported in 5% or more in either group)

Variables Ferric Citrate (n=117), n (%) Placebo (n=116), n (%)
Any treatment-emergent AE 93 (79.5) 75 (64.7)
Diarrhea 24 (20.5) 19 (16.4)
Constipation 22 (18.8) 15 (12.9)
Feces discolored 17 (14.5) 0 (0)
Nausea 13 (11.1) 3 (2.6)
Abdominal pain 7 (6.0) 2 (1.7)
Fatigue 0 (0) 6 (5.2)
Hyperkalemia 8 (6.8) 4 (3.4)
Hypertension 5 (4.3) 6 (5.2)

Events occurring during the randomized period (randomization to week 16).